In this study, we present the impact of the analytical variables CTI, anti-TFPI-abs and phospholipids (MP-reagent) on MV-associated thrombin generation in patients with pancreatic cancer and in healthy controls. The gene discussed is TFPI; the disease is familial pancreatic carcinoma.